Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158977 · ClinicalTrials.gov registry record · Phase 3
Contak Renewal 3 AVT
A Phase 3 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 73
- Enrollment target
NCT00158977 is a Phase 3 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 73 participants.
The verdict
NCT00158977, a Phase 3 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 73 participants
- Enrollment target
Study Summary
The RENEWAL 3 AVT device is designed to treat patients suffering from HF, with a history of or at risk of developing atrial and ventricular arrhythmias
Interventions
- DEVICE CONTAK RENEWAL 3 AVT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2003-11 |
| Est. Completion | 2008-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158977
The ClinicalTrials.gov registry entry for NCT00158977 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CONTAK RENEWAL 3 AVT is the first listed.
NCT00158977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158977 about?
NCT00158977 is a clinical study titled "Contak Renewal 3 AVT". The RENEWAL 3 AVT device is designed to treat patients suffering from HF, with a history of or at risk of developing atrial and ventricular arrhythmias
What is the current status of trial NCT00158977?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 73 participants. The study started on 2003-11. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00158977?
The interventions under investigation include: CONTAK RENEWAL 3 AVT (DEVICE).
Who is sponsoring clinical trial NCT00158977?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.